Saliladja, Raniesha D.
HRN: 24-56-00 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/07/2024
CEFUROXIME 1.5GM (VIAL)
11/07/2024
11/14/2024
IV
240mg
Q8h
PCAP
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes